business.financialpost.com
VBI Vaccines Regains Compliance with Nasdaq Minimum Bid Price Requirement
CAMBRIDGE, Mass. — VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI” or “the Company”), a commercial-stage biopharmaceutical company developing next-generation infectious diseas…